QIAGEN powered by
Join us at ACMG 2017 in Phoenix

QIAGEN Digital Insights Tuesday, March 7, 2017

Meet us at ACMG 2017 The American College of Medical Genetics and Genomics Annual Meeting (ACMG 2017) takes place on…

Improve your data analysis experience with our new releases

QIAGEN Digital Insights Thursday, March 2, 2017

We’re happy to announce that new releases of our products are now available. These releases offer a number of new features and improvements. You can…

Potential targeted therapies for cervical cancer

QIAGEN Digital Insights Thursday, March 2, 2017

We were pleased to see this Oncotarget report includes our software CLC Genomics Workbench as an important tool in identifying and characterizing cervical…

SOT 2017 in Baltimore

QIAGEN Digital Insights Saturday, February 25, 2017

Will you be joining our workshop? Throughout SOT 2017 you can find us in booth #1812, Exhibit Hall E. You’re also…

Supporting Rare Disease Day 2017

QIAGEN Digital Insights Friday, February 24, 2017

Research to beat rare diseases With Rare Disease Day 2017 approaching on February 28, we want to show our support. As…

Attending HIMSS17?

QIAGEN Digital Insights Tuesday, February 14, 2017

This year at HIMSS17 We’ll be joining Intel in their booth #2661 to share insights on NGS-based genetic testing across a range…

Genomics England chooses HGMD

QIAGEN Digital Insights Monday, February 6, 2017

We’re excited to report that Genomics England has selected our Human Gene Mutation Database (HGMD) for its 100,000 Genomes Project….

Sequencing European ash trees

QIAGEN Digital Insights Friday, February 3, 2017

We were delighted to read about the success of a former PhD student who spent three years working in our…

Clinical oncology testing

QIAGEN Digital Insights Tuesday, January 31, 2017

QCI Interpret’s integration of highly curated knowledge and rules enables automation for much of the interpretation and reporting process for…

Tackling Cancer Cohorts

QIAGEN Digital Insights Tuesday, January 24, 2017

Research scientist Dr. Margarete Odenthal leads the translational molecular pathology group at University Hospital Cologne, putting new technologies through their…

HGMD: an important resource for glaucoma research

QIAGEN Digital Insights Tuesday, January 24, 2017

January is National Glaucoma Awareness Month, the time of year when the Glaucoma Research Foundation seeks to raise awareness about…

Welcoming OmicSoft to the team

QIAGEN Digital Insights Tuesday, January 10, 2017

We are very pleased to announce QIAGEN’s acquisition of OmicSoft, a market-leading provider of biomarker data management, visualization and analysis…